2018-2023 Global Anti-tumor Drug Market Report (Status and Outlook)

August 2018 | 131 pages | ID: 2B3A1866B76EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Anti-tumor Drug market for 2018-2023.
Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry and genetic engineering have accelerated the process of drug development. The research and development of anti-tumor drugs have been into a new era.
In China, antitumor drugs are also the key areas of concern for many enterprises. Such as Jiangsu Hengrui, Qilu Pharmaceutical and other well-known domestic enterprises in the anti-tumor drugs have invested a lot of money, there are many innovative anti-cancer drugs into the clinical research stage. In the meantime, there has been 'explosive' growth in the development of molecularly targeted drugs, with at least hundreds of drugs under development, and it is conceivable that the market will be quite crowded in the next five to 10 years. Therefore, domestic enterprises should fully understand the feasibility of the project and the fierce market competition that they may face in the future.
China's bio-pharmaceutical industry already has a good foundation; from the national level to local governments at all levels continue to step up efforts to support the development of bio-pharmaceutical industry. The output value of the pharmaceutical industry maintained a growth rate of 20% during the 12th Five-Year Plan period. In 2013, the total output value of the pharmaceutical industry reached 2.1 trillion yuan. However, compared with the bio-pharmaceutical industry in the advanced countries in the world, there is still a huge gap between the biomedical industry in our country and the demand for building an overall well-to-do society. Mainly manifested in: small-scale enterprises, more than 10 billion yuan enterprises and more than one billion yuan less; independent innovation ability is weak, many varieties of imitation with independent intellectual property rights of the few species; restrict some of the long-term development of biomedical industry, Deep-seated problems still exist.

Over the next five years, LPI(LP Information) projects that Anti-tumor Drug will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Anti-tumor Drug market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Cytotoxic Drugs
• Non-cytotoxic Drugs

Segmentation by application:

• Alkylating Agents
• Anti-metabolism Drugs
• Platinum Antineoplastic Agents
• Anthracycline antitumor drugs
• Microtubule Stabilizer
• Endocrine Therapy Drugs
• Immunotherapy Drugs
• Gene Therapy Drugs
• Targeted Antineoplastic Drugs

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Roche
• Novartis
• Celgene
• Bristol-Myers Squibb
• Amgen
• Johnson & Johnson
• Pfizer
• Takeda
• Eli Lilly
• AstraZeneca
• Astellas
• Merck & Co
• Sanofi
• Bayer
• Biogen Idec
• Eisai
• Teva
• Otsuka

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Anti-tumor Drug market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Anti-tumor Drug market by identifying its various subsegments.
• Focuses on the key global Anti-tumor Drug players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Anti-tumor Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Anti-tumor Drug submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL ANTI-TUMOR DRUG MARKET REPORT (STATUS AND OUTLOOK)

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Anti-tumor Drug Market Size 2013-2023
  2.1.2 Anti-tumor Drug Market Size CAGR by Region
2.2 Anti-tumor Drug Segment by Type
  2.2.1 Cytotoxic Drugs
  2.2.2 Non-cytotoxic Drugs
2.3 Anti-tumor Drug Market Size by Type
  2.3.1 Global Anti-tumor Drug Market Size Market Share by Type (2013-2018)
  2.3.2 Global Anti-tumor Drug Market Size Growth Rate by Type (2013-2018)
2.4 Anti-tumor Drug Segment by Application
  2.4.1 Alkylating Agents
  2.4.2 Anti-metabolism Drugs
  2.4.3 Platinum Antineoplastic Agents
  2.4.4 Anthracycline antitumor drugs
  2.4.5 Microtubule Stabilizer
  2.4.6 Endocrine Therapy Drugs
  2.4.7 Immunotherapy Drugs
  2.4.8 Gene Therapy Drugs
  2.4.9 Targeted Antineoplastic Drugs
2.5 Anti-tumor Drug Market Size by Application
  2.5.1 Global Anti-tumor Drug Market Size Market Share by Application (2013-2018)
  2.5.2 Global Anti-tumor Drug Market Size Growth Rate by Application (2013-2018)

3 GLOBAL ANTI-TUMOR DRUG BY PLAYERS

3.1 Global Anti-tumor Drug Market Size Market Share by Players
  3.1.1 Global Anti-tumor Drug Market Size by Players (2016-2018)
  3.1.2 Global Anti-tumor Drug Market Size Market Share by Players (2016-2018)
3.2 Global Anti-tumor Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ANTI-TUMOR DRUG BY REGIONS

4.1 Anti-tumor Drug Market Size by Regions
4.2 Americas Anti-tumor Drug Market Size Growth
4.3 APAC Anti-tumor Drug Market Size Growth
4.4 Europe Anti-tumor Drug Market Size Growth
4.5 Middle East & Africa Anti-tumor Drug Market Size Growth

5 AMERICAS

5.1 Americas Anti-tumor Drug Market Size by Countries
5.2 Americas Anti-tumor Drug Market Size by Type
5.3 Americas Anti-tumor Drug Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Anti-tumor Drug Market Size by Countries
6.2 APAC Anti-tumor Drug Market Size by Type
6.3 APAC Anti-tumor Drug Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Anti-tumor Drug by Countries
7.2 Europe Anti-tumor Drug Market Size by Type
7.3 Europe Anti-tumor Drug Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Anti-tumor Drug by Countries
8.2 Middle East & Africa Anti-tumor Drug Market Size by Type
8.3 Middle East & Africa Anti-tumor Drug Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL ANTI-TUMOR DRUG MARKET FORECAST

10.1 Global Anti-tumor Drug Market Size Forecast (2018-2023)
10.2 Global Anti-tumor Drug Forecast by Regions
  10.2.1 Global Anti-tumor Drug Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Anti-tumor Drug Forecast by Type
10.8 Global Anti-tumor Drug Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Roche
  11.1.1 Company Details
  11.1.2 Anti-tumor Drug Product Offered
  11.1.3 Roche Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Roche News
11.2 Novartis
  11.2.1 Company Details
  11.2.2 Anti-tumor Drug Product Offered
  11.2.3 Novartis Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Novartis News
11.3 Celgene
  11.3.1 Company Details
  11.3.2 Anti-tumor Drug Product Offered
  11.3.3 Celgene Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Celgene News
11.4 Bristol-Myers Squibb
  11.4.1 Company Details
  11.4.2 Anti-tumor Drug Product Offered
  11.4.3 Bristol-Myers Squibb Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Bristol-Myers Squibb News
11.5 Amgen
  11.5.1 Company Details
  11.5.2 Anti-tumor Drug Product Offered
  11.5.3 Amgen Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Amgen News
11.6 Johnson & Johnson
  11.6.1 Company Details
  11.6.2 Anti-tumor Drug Product Offered
  11.6.3 Johnson & Johnson Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Johnson & Johnson News
11.7 Pfizer
  11.7.1 Company Details
  11.7.2 Anti-tumor Drug Product Offered
  11.7.3 Pfizer Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Pfizer News
11.8 Takeda
  11.8.1 Company Details
  11.8.2 Anti-tumor Drug Product Offered
  11.8.3 Takeda Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Takeda News
11.9 Eli Lilly
  11.9.1 Company Details
  11.9.2 Anti-tumor Drug Product Offered
  11.9.3 Eli Lilly Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Eli Lilly News
11.10 AstraZeneca
  11.10.1 Company Details
  11.10.2 Anti-tumor Drug Product Offered
  11.10.3 AstraZeneca Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 AstraZeneca News
11.11 Astellas
11.12 Merck & Co
11.13 Sanofi
11.14 Bayer
11.15 Biogen Idec
11.16 Eisai
11.17 Teva
11.18 Otsuka

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Anti-tumor Drug
Figure Anti-tumor Drug Report Years Considered
Figure Market Research Methodology
Figure Global Anti-tumor Drug Market Size Growth Rate 2013-2023 ($ Millions)
Table Anti-tumor Drug Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Cytotoxic Drugs
Table Major Players of Non-cytotoxic Drugs
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Anti-tumor Drug Market Size Market Share by Type (2013-2018)
Figure Global Anti-tumor Drug Market Size Market Share by Type (2013-2018)
Figure Global Cytotoxic Drugs Market Size Growth Rate
Figure Global Non-cytotoxic Drugs Market Size Growth Rate
Figure Anti-tumor Drug Consumed in Alkylating Agents
Figure Global Anti-tumor Drug Market: Alkylating Agents (2013-2018) ($ Millions)
Figure Global Alkylating Agents YoY Growth ($ Millions)
Figure Anti-tumor Drug Consumed in Anti-metabolism Drugs
Figure Global Anti-tumor Drug Market: Anti-metabolism Drugs (2013-2018) ($ Millions)
Figure Global Anti-metabolism Drugs YoY Growth ($ Millions)
Figure Anti-tumor Drug Consumed in Platinum Antineoplastic Agents
Figure Global Anti-tumor Drug Market: Platinum Antineoplastic Agents (2013-2018) ($ Millions)
Figure Global Platinum Antineoplastic Agents YoY Growth ($ Millions)
Figure Anti-tumor Drug Consumed in Anthracycline antitumor drugs
Figure Global Anti-tumor Drug Market: Anthracycline antitumor drugs (2013-2018) ($ Millions)
Figure Global Anthracycline antitumor drugs YoY Growth ($ Millions)
Figure Anti-tumor Drug Consumed in Microtubule Stabilizer
Figure Global Anti-tumor Drug Market: Microtubule Stabilizer (2013-2018) ($ Millions)
Figure Global Microtubule Stabilizer YoY Growth ($ Millions)
Table Global Anti-tumor Drug Market Size by Application (2013-2018) ($ Millions)
Table Global Anti-tumor Drug Market Size Market Share by Application (2013-2018)
Figure Global Anti-tumor Drug Market Size Market Share by Application (2013-2018)
Figure Global Anti-tumor Drug Market Size in Alkylating Agents Growth Rate
Figure Global Anti-tumor Drug Market Size in Anti-metabolism Drugs Growth Rate
Figure Global Anti-tumor Drug Market Size in Platinum Antineoplastic Agents Growth Rate
Figure Global Anti-tumor Drug Market Size in Anthracycline antitumor drugs Growth Rate
Figure Global Anti-tumor Drug Market Size in Microtubule Stabilizer Growth Rate
Figure Global Anti-tumor Drug Market Size in Endocrine Therapy Drugs Growth Rate
Figure Global Anti-tumor Drug Market Size in Immunotherapy Drugs Growth Rate
Figure Global Anti-tumor Drug Market Size in Gene Therapy Drugs Growth Rate
Figure Global Anti-tumor Drug Market Size in Targeted Antineoplastic Drugs Growth Rate
Table Global Anti-tumor Drug Revenue by Players (2016-2018) ($ Millions)
Table Global Anti-tumor Drug Revenue Market Share by Players (2016-2018)
Figure Global Anti-tumor Drug Revenue Market Share by Players in 2017
Table Global Anti-tumor Drug Key Players Head office and Products Offered
Table Anti-tumor Drug Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Anti-tumor Drug Market Size by Regions 2013-2018 ($ Millions)
Table Global Anti-tumor Drug Market Size Market Share by Regions 2013-2018
Figure Global Anti-tumor Drug Market Size Market Share by Regions 2013-2018
Figure Americas Anti-tumor Drug Market Size 2013-2018 ($ Millions)
Figure APAC Anti-tumor Drug Market Size 2013-2018 ($ Millions)
Figure Europe Anti-tumor Drug Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Anti-tumor Drug Market Size 2013-2018 ($ Millions)
Table Americas Anti-tumor Drug Market Size by Countries (2013-2018) ($ Millions)
Table Americas Anti-tumor Drug Market Size Market Share by Countries (2013-2018)
Figure Americas Anti-tumor Drug Market Size Market Share by Countries in 2017
Table Americas Anti-tumor Drug Market Size by Type (2013-2018) ($ Millions)
Table Americas Anti-tumor Drug Market Size Market Share by Type (2013-2018)
Figure Americas Anti-tumor Drug Market Size Market Share by Type in 2017
Table Americas Anti-tumor Drug Market Size by Application (2013-2018) ($ Millions)
Table Americas Anti-tumor Drug Market Size Market Share by Application (2013-2018)
Figure Americas Anti-tumor Drug Market Size Market Share by Application in 2017
Figure United States Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Canada Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Table APAC Anti-tumor Drug Market Size by Countries (2013-2018) ($ Millions)
Table APAC Anti-tumor Drug Market Size Market Share by Countries (2013-2018)
Figure APAC Anti-tumor Drug Market Size Market Share by Countries in 2017
Table APAC Anti-tumor Drug Market Size by Type (2013-2018) ($ Millions)
Table APAC Anti-tumor Drug Market Size Market Share by Type (2013-2018)
Figure APAC Anti-tumor Drug Market Size Market Share by Type in 2017
Table APAC Anti-tumor Drug Market Size by Application (2013-2018) ($ Millions)
Table APAC Anti-tumor Drug Market Size Market Share by Application (2013-2018)
Figure APAC Anti-tumor Drug Market Size Market Share by Application in 2017
Figure China Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Japan Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Korea Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure India Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Australia Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Table Europe Anti-tumor Drug Market Size by Countries (2013-2018) ($ Millions)
Table Europe Anti-tumor Drug Market Size Market Share by Countries (2013-2018)
Figure Europe Anti-tumor Drug Market Size Market Share by Countries in 2017
Table Europe Anti-tumor Drug Market Size by Type (2013-2018) ($ Millions)
Table Europe Anti-tumor Drug Market Size Market Share by Type (2013-2018)
Figure Europe Anti-tumor Drug Market Size Market Share by Type in 2017
Table Europe Anti-tumor Drug Market Size by Application (2013-2018) ($ Millions)
Table Europe Anti-tumor Drug Market Size Market Share by Application (2013-2018)
Figure Europe Anti-tumor Drug Market Size Market Share by Application in 2017
Figure Germany Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure France Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure UK Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Italy Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Russia Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Spain Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Anti-tumor Drug Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Anti-tumor Drug Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Anti-tumor Drug Market Size Market Share by Countries in 2017
Table Middle East & Africa Anti-tumor Drug Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Anti-tumor Drug Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Anti-tumor Drug Market Size Market Share by Type in 2017
Table Middle East & Africa Anti-tumor Drug Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Anti-tumor Drug Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Anti-tumor Drug Market Size Market Share by Application in 2017
Figure Egypt Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Israel Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Anti-tumor Drug Market Size Growth 2013-2018 ($ Millions)
Figure Global Anti-tumor Drug arket Size Forecast (2018-2023) ($ Millions)
Table Global Anti-tumor Drug Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Anti-tumor Drug Market Size Market Share Forecast by Regions
Figure Americas Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure APAC Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Europe Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure United States Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Canada Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Mexico Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Brazil Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure China Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Japan Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Korea Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure India Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Australia Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Germany Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure France Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure UK Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Italy Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Russia Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Spain Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Egypt Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure South Africa Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Israel Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure Turkey Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Figure GCC Countries Anti-tumor Drug Market Size 2018-2023 ($ Millions)
Table Global Anti-tumor Drug Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Anti-tumor Drug Market Size Market Share Forecast by Type (2018-2023)
Table Global Anti-tumor Drug Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Anti-tumor Drug Market Size Market Share Forecast by Application (2018-2023)
Table Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table Roche Anti-tumor Drug Revenue and Gross Margin (2016-2018)
Figure Roche Anti-tumor Drug Market Share (2016-2018)
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Anti-tumor Drug Revenue and Gross Margin (2016-2018)
Figure Novartis Anti-tumor Drug Market Share (2016-2018)
Table Celgene Basic Information, Head Office, Major Market Areas and Its Competitors
Table Celgene Anti-tumor Drug Revenue and Gross Margin (2016-2018)
Figure Celgene Anti-tumor Drug Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bristol-Myers Squibb Anti-tumor Drug Revenue and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Anti-tumor Drug Market Share (2016-2018)
Table Amgen Basic Information, Head Office, Major Market Areas and Its Competitors
Table Amgen Anti-tumor Drug Revenue and Gross Margin (2016-2018)
Figure Amgen Anti-tumor Drug Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Head Office, Major Market Areas and Its Competitors
Table Johnson & Johnson Anti-tumor Drug Revenue and Gross Margin (2016-2018)
Figure Johnson & Johnson Anti-tumor Drug Market Share (2016-2018)
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Anti-tumor Drug Revenue and Gross Margin (2016-2018)
Figure Pfizer Anti-tumor Drug Market Share (2016-2018)
Table Takeda Basic Information, Head Office, Major Market Areas and Its Competitors
Table Takeda Anti-tumor Drug Revenue and Gross Margin (2016-2018)
Figure Takeda Anti-tumor Drug Market Share (2016-2018)
Table Eli Lilly Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eli Lilly Anti-tumor Drug Revenue and Gross Margin (2016-2018)
Figure Eli Lilly Anti-tumor Drug Market Share (2016-2018)
Table AstraZeneca Basic Information, Head Office, Major Market Areas and Its Competitors
Table AstraZeneca Anti-tumor Drug Revenue and Gross Margin (2016-2018)
Figure AstraZeneca Anti-tumor Drug Market Share (2016-2018)
Table Astellas Basic Information, Head Office, Major Market Areas and Its Competitors
Table Merck & Co Basic Information, Head Office, Major Market Areas and Its Competitors
Table Sanofi Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bayer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Biogen Idec Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eisai Basic Information, Head Office, Major Market Areas and Its Competitors
Table Teva Basic Information, Head Office, Major Market Areas and Its Competitors
Table Otsuka Basic Information, Head Office, Major Market Areas and Its Competitors